Literature DB >> 15168301

[The V.A.C. system (vacuum assisted closure) as bridging between primary osteosynthesis in conjunction with functional reconstructed of soft tissue--open fractures type 2 and type 3].

A E Steiert1, A Partenheimer, T Schreiber, T Muehlberger, C Krettek, L U Lahoda, P M Vogt.   

Abstract

Open fractures are complex injuries affecting the integrity of bones and adjacent soft tissue. The therapeutic goals in dealing with open fractures should consist of primary osteosynthesis in conjunction with functional reconstruction of soft tissue. In a period over 2 years, 26 patients were treated with extensive trauma in an interdisciplinary approach. These patients suffered from open fractures type 2 and 3. All patients were treated by primary osteosynthesis, and temporary wound closure with V.A.C.-system. Definitive wound closure was achieved by day 31 after injury. In contrast to a review of the pertinent literature we report the successful free tissue transfer in 21 patients during the critical period between 72 hours and several months preceded by the use of V.A.C.-system for the temporary coverage of open wounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168301     DOI: 10.1055/s-2004-822658

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  3 in total

Review 1.  [Prevention of infection in the current treatment of open fractures: an evidence-based systematic analysis].

Authors:  S Grote; H Polzer; W C Prall; S Gill; S Shafizadeh; M Banerjee; B Bouillon; H Bäthis
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

Review 2.  [Vacuum-assisted closure therapy and wound coverage in soft tissue injury. Clinical use].

Authors:  G Holle; G Germann; M Sauerbier; K Riedel; H von Gregory; M Pelzer
Journal:  Unfallchirurg       Date:  2007-04       Impact factor: 1.000

3.  The principles and practice of open fracture care, 2018.

Authors:  Amna Diwan; Kyle R Eberlin; Raymond Malcolm Smith
Journal:  Chin J Traumatol       Date:  2018-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.